Yvonne L. Greenstreet
2019
In 2019, Yvonne L. Greenstreet earned a total compensation of $3.3M as President and Chief Operating Officer at Alnylam Pharmaceuticals, a 21% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $370,875 |
|---|---|
| Option Awards | $1,654,494 |
| Salary | $571,423 |
| Stock Awards | $460,360 |
| Other | $192,873 |
| Total | $3,250,025 |
Greenstreet received $1.7M in option awards, accounting for 51% of the total pay in 2019.
Greenstreet also received $370.9K in non-equity incentive plan, $571.4K in salary, $460.4K in stock awards and $192.9K in other compensation.
Rankings
In 2019, Yvonne L. Greenstreet's compensation ranked 3,748th out of 13,971 executives tracked by ExecPay. In other words, Greenstreet earned more than 73.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,748 out of 13,971 | 73rd |
Division Manufacturing | 1,356 out of 5,701 | 76th |
Major group Chemicals And Allied Products | 473 out of 2,200 | 79th |
Industry group Drugs | 397 out of 1,886 | 79th |
Industry Pharmaceutical Preparations | 300 out of 1,398 | 79th |
Source: SEC filing on April 2, 2021.
Greenstreet's colleagues
We found five more compensation records of executives who worked with Yvonne L. Greenstreet at Alnylam Pharmaceuticals in 2019.
2019
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2019
Jeffrey Poulton
Alnylam Pharmaceuticals
Chief Financial Officer
2019
Barry Greene
Alnylam Pharmaceuticals
Former President
2019
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
2019
Laurie Keating
Alnylam Pharmaceuticals